Meningitis Outbreak Expands to Second University in Kent
A second university in Kent has confirmed cases of meningitis among its student population, as health officials report a total of 20 infections linked to the ongoing outbreak. Canterbury Christ Church University announced that the disease has been detected within its student body, joining the University of Kent, which had previously been the sole higher education institution affected. The outbreak, which originated in Kent, has now resulted in two fatalities: an 18-year-old sixth-form pupil from Queen Elizabeth's Grammar School in Faversham and a 21-year-old University of Kent student.
Vaccine Rollout Initiates Amid Rising Case Numbers
The University of Kent, in collaboration with the UK Health Security Agency (UKHSA), has commenced a targeted meningitis B vaccine programme for approximately 5,000 students residing on its Canterbury campus. This rollout began on Wednesday, alongside the continued distribution of antibiotics to students and staff as a preventative measure. Health Secretary Wes Streeting described the spread as "unprecedented" due to its rapid pace, prompting proactive interventions.
National Vaccine Shortages and Public Response
Pharmacies across the UK are facing a national shortage of meningitis B vaccines, with Boots and Superdrug implementing waiting lists and queuing systems due to high demand. Olivier Picard, chairman of the National Pharmacy Association, reported that private stock has run out, leaving many unable to access vaccinations. Meanwhile, the UKHSA has advised GPs nationwide to prescribe antibiotics to individuals who visited Club Chemistry in Canterbury between March 5 and 7, as well as to University of Kent students, to curb further transmission.
Expert Insights and Wider Implications
Infectious disease experts have labeled the outbreak a "super-spreader event," with UKHSA chief executive Susan Hopkins noting it as the most cases she has witnessed in a single weekend over her 35-year career. While the likelihood of wider spread beyond Kent is considered low, Professor Paul Hunter from the University of East Anglia cautioned that secondary cases are possible. French authorities have confirmed one stable case linked to the outbreak, with no further reports in France, and health officials in Northern Ireland are investigating an unrelated probable case in Belfast.
Impact on Schools and Community
As many as five schools in Kent have reported infections among pupils, with The Canterbury Academy being the latest addition. The UKHSA has mapped areas below the World Health Organization's target of a 95% vaccination rate, highlighting regions like Hackney, Manchester, and Birmingham with particularly low rates. Health officials urge vigilance for symptoms, emphasizing that antibiotics remain the most effective immediate treatment, reducing household risk by 80-90%.
The number of cases is expected to rise due to the infection's incubation period of two to 14 days, with ongoing investigations into 11 of the 20 reported cases. The UKHSA continues to monitor the situation closely, offering reassurance that there is no current evidence of wider national spread, but stressing the importance of up-to-date vaccinations and prompt medical attention if symptoms arise.
